Highest-materiality recent filing
ProAssurance Q1 operating income $12.7M; merger with Doctors Company targets June 30 close
Net income $8.5M ($0.16 diluted EPS); operating income $12.7M ($0.25 diluted EPS).
ProAssurance reports Q4 net income $33.4M ($0.64 EPS); merger update
Q4 net income $33.4M ($0.64 diluted EPS); operating income $42.4M ($0.82 diluted EPS).
ProAssurance approves early bonus payouts to NEOs to mitigate Section 280G impact
Compensation Committee approved early payments of ~80% of 2025 annual cash incentive awards to NEOs.
ProAssurance Q3 net income $1.4M; merger with Doctors Co. pending regulatory approvals
Q3 net income $1.4M ($0.03 diluted EPS); operating income $7.9M ($0.15 diluted EPS).
ProAssurance reports Q2 net income $21.9M ($0.42 EPS); merger with Doctors Co. on track
Net income $21.9M ($0.42 diluted EPS); operating income $26.8M ($0.52 diluted EPS) for Q2 2025.
FTC grants early termination of HSR waiting period for ProAssurance acquisition by Doctors Company
U.S. FTC granted early termination of HSR Act waiting period on July 2, 2025.
ProAssurance shareholders approve acquisition by The Doctors Company with over 99% vote in favor
Stockholders voted 38,225,337 for, 363,050 against, 22,192 abstain; over 99% of votes cast in favor.
ProAssurance elects three directors, board reduced to nine; audit chair changed
Stockholders elected DiPiazza, Frei, and Syphax to three-year terms at May 21, 2025 annual meeting.
our stockholders elected Samuel A. DiPiazza, Jr., C.P.A., Maye Head Frei, and Scott C. Syphax to our Board of Directors
Kedrick D. Adkins, C.P.A., who had served on the Board for seven years, did not stand for re-election
our stockholders elected Samuel A. DiPiazza, Jr., C.P.A., Maye Head Frei, and Scott C. Syphax to our Board of Directors
our stockholders elected Samuel A. DiPiazza, Jr., C.P.A., Maye Head Frei, and Scott C. Syphax to our Board of Directors
Max materiality 0.80 · Median 0.68 · Most common event earnings